You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Exercise Disclosure
Sabag Mark · SEC Form 4 · Filed Nov 6, 2026
Exercise
Calculated transaction value
$0
Sabag Mark See "remarks"
TEVA
Transaction date
Nov 5, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 1 day later
TEVA daily price context
Close on/before transaction
$41.78
Nov 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (right to buy) on Ordinary Shares
- Quantity / price
- 46,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-451814
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$3.53M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Nov 5, 2026 | $1.61M |
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Nov 5, 2026 | $1.93M |
| Teva Pharmaceutical Industries Ltd TEVA Current | Exercise | Nov 5, 2026 | $0 |